0001140361-18-027607.txt : 20180606 0001140361-18-027607.hdr.sgml : 20180606 20180606202129 ACCESSION NUMBER: 0001140361-18-027607 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180430 FILED AS OF DATE: 20180606 DATE AS OF CHANGE: 20180606 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Davis George Eric CENTRAL INDEX KEY: 0001380710 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 18885019 MAIL ADDRESS: STREET 1: C/O BIOMARIN PHARMACEUTICAL INC. STREET 2: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0306 4 2018-04-30 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001380710 Davis George Eric C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO ST. SAN RAFAEL CA 94901 0 1 0 0 EVP, General Counsel Common Stock 2018-04-30 2018-04-30 4 A 0 309 68.782 A 88364 D Common Stock 2018-06-04 2018-06-04 4 F 0 1414 92.070 D 86950 D Represents shares acquired by the reporting person on April 30, 2018, pursuant to the issuer's Employee Stock Purchase Plan. Amount of securities beneficially owned has been adjusted from the reporting person's prior report to: a) add 79 shares reported as acquired in the Form 4 Amendment filed with the S.E.C. on 4/26/2018; and b) subtract 13 shares reported as disposed of in the Form 4 Amendment filed with the S.E.C. on 4/27/2018. /s/ Laura Randall Woodhead, Attorney-in-Fact 2018-06-06